Showing stories 1 - 10 of about 30
IMMUNOMEDICS, INC. : IMMUNOMEDICS ANNOUNCES THREE NEW ...
Related articles »
IMMUNOMEDICS ANNOUNCES THREE NEW PATENT AWARDS -- The Company Ranked Tenth in the World for US Patents in Biotechnology/Pharmaceuticals -- Morris Plains, NJ, May 7, 2013 --- Immunomedics, Inc. (Nasdaq: IMMU), a biopharmaceutical ...
Immunomedics Announces Three New Patent Awards
GlobeNewswire (press release)Related articles »
IMMUNOMEDICS, INC. : IMMUNOMEDICS ANNOUNCES THIRD QUARTER ...
Related articles »
IMMUNOMEDICS ANNOUNCES THIRD QUARTER FISCAL 2013 RESULTS AND CLINICAL PROGRAM DEVELOPMENTS Morris Plains, NJ, May 8, 2013 --- Immunomedics, Inc. (Nasdaq: IMMU), a biopharmaceutical company primarily focused on the ...
Immunomedics Announces Third Quarter Fiscal 2013 Results and Clinical ...
GlobeNewswire (press release)Related articles »
IMMUNOMEDICS, INC. : IMMUNOMEDICS ANNOUNCES CONFERENCE CALL ...
IMMUNOMEDICS ANNOUNCES CONFERENCE CALL AND WEBCAST FOR THIRD QUARTER FISCAL 2013 FINANCIAL RESULTS Morris Plains, NJ, April 25, 2013 --- Immunomedics, Inc. (Nasdaq: IMMU), a biopharmaceutical company primarily focused ...
Related articles »
PropThink Biotech Stocks to Buy with Big Gains: Cubist, Immunomedics and More
Immunomedics Inc. (NASDAQ: IMMU) is on the radar screen as a possible option trade candidate. Immunomedics is a biopharmaceutical company engaged in the research, development, manufacture and marketing of monoclonal, antibody-based products ...
Best & Worst Biotech Stocks Amid News: Questcor, Dendreon, Affymax ...
Immunomedics, Inc. (NASDAQ:IMMU) traded 6.12% higher to close last trading session at $2.95, extending three-day winning streak after its 3Q results topped expectations.
Related articles »
Cancer Diagnostic Testing World Markets
... Inc. (formerly Cytyc Corporation) 2246.42 Immunicon Corporation (now Veridex, LLC) 2286.43 Immunomedics, Inc. 2286.44 Ipsogen 2296.45 LabCorp 2296.46 Urocor, Inc. 2306.47 Mitsubishi Kagaku Medical 2316.48 Molecular Devices (formerly Arcturus ...
Related articles »
Immunomedics Earnings: Your Sneak Peek to the Big Announcement
Immunomedics (NASDAQ:IMMU) will report earnings after markets close on Wednesday, May 8th. Immunomedics, Inc. develops, manufactures, and sells diagnostic imaging and therapeutic products.
Related articles »
Immunomedics Incorporated (IMMU) Announces Quarterly Earnings, Beats ...
Immunomedics, Inc. (NASDAQ: IMMU) is a biopharmaceutical company focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases.
In Danish Laboratories, Hope Looms Large for a Permanent HIV Cure
Immunomedics, Inc. (NASDAQ:IMMU) is working with the Karolinska Institutet to develop a new class of drugs designed to vanquish the virus, not just control it.
Related articles »
DIARY-NON S&P WEEK AHEAD
N/A N/A N/A 08 May AMC Q1 2013 IntraLinks 0.02 6 0.02 08 May AMC Q3 2013 Immunomedics -0.10 5 -0.10 08 May AMC Q2 2013 INTL FCStone Inc 0.45 1 0.20 08 May AMC Q1 2013 Inter Parfums, Inc. 0.60 5 0.51 08 May AMC Q1 2013 iPass Inc. -0.04 ...
Related articles »